Short Information | Merck & Company Inc. (NYSE:MRK)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 319,314 |
Total Actual Volume | 212,688,294 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 15,966 |
Average Short Percentage | 0.19% |
Is there a MRK Short Squeeze or Breakout about to happen?
See the MRK Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $128.21 | $127.72 | $128.24 | $126.66 | 5,644,608 | 3,577 | 0.06% |
07-01-2024 | $125.38 | $127.9 | $129.19 | $125.1 | 11,532,966 | 23,600 | 0.2% |
06-28-2024 | $129.54 | $123.8 | $130.97 | $120.87 | 57,055,458 | 15,387 | 0.03% |
06-27-2024 | $131.99 | $129.82 | $132.29 | $126.78 | 11,927,599 | 21,726 | 0.18% |
06-26-2024 | $133.38 | $131.5 | $133.43 | $131.49 | 8,492,119 | 10,535 | 0.12% |
06-25-2024 | $133.12 | $132.92 | $134.63 | $132.6039 | 6,758,429 | 17,831 | 0.26% |
06-24-2024 | $131.27 | $132.96 | $133.31 | $130.925 | 8,554,044 | 4,408 | 0.05% |
06-21-2024 | $130.17 | $130.72 | $131.2 | $129.09 | 17,182,704 | 7,844 | 0.05% |
06-20-2024 | $127.39 | $129.67 | $130.4263 | $126.75 | 10,348,371 | 56,166 | 0.54% |
06-18-2024 | $128.27 | $127.99 | $128.73 | $127.0901 | 6,532,400 | 5,250 | 0.08% |
06-17-2024 | $128.21 | $127.5 | $128.94 | $127.37 | 8,524,031 | 8,771 | 0.1% |
06-14-2024 | $129.16 | $129.48 | $129.87 | $128.65 | 7,338,462 | 32,315 | 0.44% |
06-13-2024 | $130.02 | $129.37 | $130.12 | $128.5901 | 5,004,226 | 5,748 | 0.11% |
06-12-2024 | $132.7 | $130.2 | $132.71 | $130.1631 | 5,821,965 | 7,622 | 0.13% |
06-11-2024 | $131 | $131.84 | $132.17 | $129.74 | 11,453,195 | 6,172 | 0.05% |
06-10-2024 | $130.63 | $131.49 | $131.68 | $129.65 | 6,033,808 | 40,937 | 0.68% |
06-07-2024 | $130.35 | $130.67 | $131.37 | $130.21 | 4,945,599 | 11,626 | 0.24% |
06-06-2024 | $129.16 | $130.52 | $130.93 | $128.9 | 8,088,641 | 24,090 | 0.3% |
06-05-2024 | $128.48 | $129.45 | $129.94 | $128.07 | 5,009,502 | 3,703 | 0.07% |
06-04-2024 | $127.15 | $128.71 | $129.3599 | $126.88 | 6,440,167 | 12,006 | 0.19% |
News, Short Squeeze, Breakout and More Instantly...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Orion Corporation (“Orion”) today announced that notice has been provided of the mutual exercise of an option to convert the companies’ ongoing co-development and co-commercialization agreement for o...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its second-quarter 2024 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Tuesday, July 30. During the call, company executives will provide an overview of Merck’...
If approved by the European Commission, WINREVAIR will be the first activin signaling inhibitor therapy for PAH in Europe, offering a new treatment option for certain adults with this rare, progressive disease Milestone highlights Merck’s focus on global filings to expand access to...